E1	Eq-Comparison:T1 Value:T31 Temporal-Unit:T32 Operator:T33
E3	Study:T3 
E4	Modifier:T4 Modifies:T34
E5	Condition:T5 Name:T34
E6	Procedure:T6 Name:T35
E7	Eq-Comparison:T7 Operator:T36 Value:T37 Operator:T38 Value:T39 Temporal-Unit:T40
E8	Observation:T8 Name:T41 Numeric-Filter:E7
E9	Observation:T9 Name:T42 Numeric-Filter:E10
E10	Eq-Comparison:T10 Value:T43 Operator:T44 Value:T45 Temporal-Unit:T46
E12	Study:T12 
E13	Condition:T13 Name:T47
E15	Condition:T15 Name:T48
E17	Condition:T17 Name:T49 Temporality:E32
E18	Contraindication:T18 Contraindicates:E19
E19	Drug:T19 Name:T50 Dose:E20
E20	Eq-Comparison:T20 Value:T51 Unit:T52 Operator:T61 Unit2:T62
E21	Eq-Comparison:T21 
E22	Eq-Comparison:T22 Temporal-Period:T53
E23	Drug:T23 Name:T54 Temporality:E22
E24	Condition:T24 Name:T55
E25	Condition:T25 
E27	Condition:T27 
E28	Assertion:T28 Asserted:T65
E29	Risk:T29 
E30	Age:T56 Numeric-Filter:E1
E31	Assertion:T57 Asserted:E6
E32	Eq-Comparison:T58 Temporal-Period:T59
E33	Modifier:T60 Modifies:T50
E34	Modifier:T63 Modifies:T55
E35	Study:T66 Stability:T65
T1	Eq-Comparison 31 55	18 years of age or older
T3	Study 59 69	enrollment
T4	Modifier 94 110	viable singleton
T5	Condition 111 120	pregnancy
T6	Procedure 153 166	GDM screening
T7	Eq-Comparison 167 186	between 24-28 weeks
T8	Observation 187 196	gestation
T9	Observation 216 231	gestational age
T10	Eq-Comparison 235 246	24-28 weeks
T12	Study 254 263	Screening
T13	Condition 369 377	diabetes
T15	Condition 385 394	pregnancy
T17	Condition 430 433	GDM
T18	Contraindication 443 460	contraindications
T19	Drug 479 486	glucose
T20	Eq-Comparison 496 516	up to 100 g of sugar
T21	Eq-Comparison 519 520	3
T22	Eq-Comparison 525 531	taking
T23	Drug 532 541	metformin
T24	Condition 582 589	illness
T25	Condition 591 598	disease
T27	Condition 602 611	condition
T28	Assertion 667 673	likely
T29	Risk 789 793	risk
T30	Life-Stage-And-Gender 25 30	Women
T31	Eq-Value 31 33	18
T32	Eq-Temporal-Unit 34 39	years
T33	Eq-Operator 47 55	or older
T34	Condition-Name 111 120	pregnancy
T35	Procedure-Name 153 166	GDM screening
T36	Eq-Operator 167 174	between
T37	Eq-Value 175 177	24
T38	Eq-Operator 177 178	-
T39	Eq-Value 178 180	28
T40	Eq-Temporal-Unit 181 186	weeks
T41	Observation-Name 187 196	gestation
T42	Observation-Name 216 231	gestational age
T43	Eq-Value 235 237	24
T44	Eq-Operator 237 238	-
T45	Eq-Value 238 240	28
T46	Eq-Temporal-Unit 241 246	weeks
T47	Condition-Name 369 377	diabetes
T48	Condition-Name 385 394	pregnancy
T49	Condition-Name 430 433	GDM
T50	Drug-Name 479 486	glucose
T51	Eq-Value 502 505	100
T52	Eq-Unit 506 507	g
T53	Eq-Temporal-Period 525 531	taking
T54	Drug-Name 532 541	metformin
T55	Condition-Name 582 589	illness
T56	Age 43 46	age
T57	Assertion 129 144	recommended for
T58	Eq-Comparison 402 409	already
T59	Eq-Temporal-Period 402 409	already
T60	Modifier 465 478	drinking oral
T61	Eq-Operator 496 501	up to
T62	Eq-Unit 511 516	sugar
T63	Modifier 570 581	concomitant
T64	Condition-Name 591 598	disease
T65	Stability 677 684	prevent
T66	Study 735 743	protocol
A4	Assertion-Type-Value E28 hypothetical
A5	Life-Stage-And-Gender-Type T30 female
A6	Eq-Temporal-Unit-Value T32 year
A7	Eq-Operator-Value T33 GTEQ
A8	Eq-Operator-Value T36 BETWEEN
A9	Eq-Operator-Value T38 BETWEEN
A10	Eq-Temporal-Unit-Value T40 week
A11	Observation-Type-Value E8 measurement
A12	Eq-Operator-Value T44 BETWEEN
A13	Eq-Temporal-Unit-Value T46 week
A14	Eq-Temporal-Period-Value T53 present
A15	Assertion-Type-Value E31 hypothetical
A16	Observation-Type-Value E9 measurement
A17	Eq-Temporal-Period-Value T59 past
A18	Eq-Operator-Value T61 LTEQ
A19	Stability-Value T65 change
R1	Caused-By Arg1:T65 Arg2:E24
R2	Caused-By Arg1:T65 Arg2:E25
R3	Caused-By Arg1:T65 Arg2:E27
R4	Caused-By Arg1:E29 Arg2:E24
R5	Caused-By Arg1:E29 Arg2:E25
R6	Caused-By Arg1:E29 Arg2:E27
R7	During Arg1:E30 Arg2:E3
R8	During Arg1:E9 Arg2:E12
R9	Before Arg1:E13 Arg2:E15
R10	Or Arg1:E15 Arg2:E17
R11	Or Arg1:E25 Arg2:E27
R12	Or Arg1:E35 Arg2:E29
R13	Or Arg1:E24 Arg2:E25
